The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1084
August 7, 2000
View Complete Issue         Table of Contents 2019 
Cevimeline (Evoxac) For Dry Mouth
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Cevimeline (Evoxac) For Dry Mouth
August 7, 2000 (Issue: 1084)
Cevimeline hydrochloride, an acetylcholine derivative, has been approved by the FDA for treatment of dry mouth symptoms caused by Sjogren's syndrome. Presumably it could also be used to treat radiation-induced xerostomia in patients with head and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Cevimeline (Evoxac) For Dry Mouth
Article code: 1084b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.